Ispecimen revenue was $10.39M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $2.7M, down 7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ISPC annual revenue was $9.9M, with -4.6% growth year-over-year.
ISPC past revenue growth
How has ISPC's revenue growth performed historically?
Ispecimen (NASDAQ: ISPC) reported Q3 2024 revenue of $2.66 million up 4.17% year over year. In the same quarter last year, Ispecimen's revenue was $2.78 million.
What was Ispecimen's revenue in 2023?
Ispecimen's annual revenue for the twelve months ending Dec 31, 2023 was $9.93 million, a 4.56% decrease year over year.
How much does Ispecimen make in a day?
Based on Ispecimen annual revenue for the past four years, ISPC makes an average of $27,157.46 per day.
What was Ispecimen's annual revenue growth in the past year?
As of Q4 2024, Ispecimen's revenue has grown 0.74% year over year. This is 0.29 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 1.03%. Ispecimen's revenue in the past year totaled $10.39 million.
How much does Ispecimen make in a year?
Ispecimen's revenue by year for the past four years is:
Ispecimen's revenue for the twelve months ending Dec 31, 2023 was $9.93 million, a 4.56% decrease year over year.
Ispecimen's annual revenue for Dec 31, 2022 was $10.40 million, a 6.58% decrease from 2021.
Ispecimen's annual revenue for 2021 was $11.14 million, a 36.06% increase from 2020.
Ispecimen's annual revenue for 2020 was $8.18 million, a 90.4% increase from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.